VNRX icon

VolitionRX
VNRX

Overview Fund Activity

17 hedge funds and large institutions have $17.4M invested in VolitionRX in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
–
Increased
5
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
LIM
1
Lagoda Investment Management
New York
$11.2M
2
Bank of New York Mellon
2
Bank of New York Mellon
New York
$108K
3
UBS Group
3
UBS Group
Switzerland
$19K
4
TRCT
4
Tower Research Capital (TRC)
New York
$4K
5
BlackRock
5
BlackRock
New York
$38K

Top Sellers

1
SCA
1
Southpoint Capital Advisors
New York
$2.8M
Name Market Value Shares Shares
Change 		Shares
Change %
LIM
1
Lagoda Investment Management
New York
$11.2M 3,155,692 +216,613 +7%
SCA
2
Southpoint Capital Advisors
New York
$2.8M 792,000 -8,000 -1%
KCM
3
Knoll Capital Management
Florida
$1.62M 461,538 – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$725K 204,994 – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$357K 100,890 – –
Morgan Stanley
6
Morgan Stanley
New York
$209K 58,900 – –
Bank of New York Mellon
7
Bank of New York Mellon
New York
$108K 30,376 +19,414 +177%
Northern Trust
8
Northern Trust
Illinois
$80K 22,714 – –
GBA
9
Garrison Bradford & Associates
New York
$55K 15,500 – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$50K 14,000 – –
Creative Planning
11
Creative Planning
Kansas
$47K 13,200 – –
BlackRock
12
BlackRock
New York
$38K 10,584 +508 +5%
Bessemer Group
13
Bessemer Group
New Jersey
$35K 10,000 – –
AG
14
Advisor Group
Arizona
$27K 7,500 – –
UBS Group
15
UBS Group
Switzerland
$19K 5,324 +1,745 +49%
TRCT
16
Tower Research Capital (TRC)
New York
$4K 1,224 +724 +145%
IP
17
Intellectus Partners
California
$1K 283 – –